BNP Paribas Financial Markets
OPTR

BNP Paribas Financial Markets’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

BNP Paribas Financial Markets’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-13,269
Closed -$167K – 4209
2013
Q3 		$167K Sell
13,269
-3,357
-20% -$44.5K ﹤0.01% 2308
2013
Q2 		$241K Buy
+16,626
New +$242K ﹤0.01% 2187

BNP Paribas Financial Markets's OPTR Position: Q4 2013 in Review

BNP Paribas Financial Markets sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 13,269 shares — an estimated $167K sold.

BNP Paribas Financial Markets first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $241K in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • BNP Paribas Financial Markets reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 13,269 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $167K.
  • BNP Paribas Financial Markets first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • BNP Paribas Financial Markets's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $241K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2013, filed 12 Feb 2014.